Compound Evidence File
#EC-2026-0804
GHRP-6 Acetate
Filed under Peptides. The bureau holds 98 laboratory returns for this compound from 36 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
36 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 9.4 | 9.4 | 9.4 | 2 Apr 2025 | 2 Apr 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 5 | 8.9 | 7.5 | 10.0 | 27 Feb 2025 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.6 | 7.9 | 9.4 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.5 | 6.8 | 9.4 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.4 | 6.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.4 | 7.4 | 9.7 | 24 May 2026 | 24 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 8.3 | 8.3 | 8.3 | 13 Feb 2025 | 13 Feb 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.2 | 7.9 | 8.4 | 23 May 2026 | 23 May 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 | 27 Feb 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 | 3 Jul 2025 |
| PeptiSlimCASE #VI-2026-0557 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 | 21 May 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.9 | 7.9 | 7.9 | 25 Apr 2025 | 25 Apr 2025 |
| LSPLCASE #VI-2026-0523 | X | 4 | 7.8 | 6.5 | 8.7 | 7 May 2025 | 17 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 8 | 7.7 | 6.1 | 10.0 | 11 Jun 2025 | 17 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 5 | 7.6 | 5.9 | 9.9 | 7 May 2025 | 26 Jan 2026 |
| HXNetCASE #VI-2026-0061 | X | 4 | 7.6 | 5.0 | 9.0 | 20 Jun 2025 | 24 May 2026 |
| Shanghai ERP peptide BiotechnologyCASE #VI-2026-0500 | X | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 | 2 Jul 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 | 16 Mar 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 7.4 | 5.9 | 8.8 | 8 Jul 2025 | 26 Jan 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 7.3 | 7.3 | 7.3 | 13 Jun 2025 | 13 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 7.0 | 7.0 | 7.0 | 25 Apr 2025 | 25 Apr 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 6.8 | 6.8 | 6.8 | 9 Jun 2025 | 9 Jun 2025 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 | 25 Apr 2025 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 6.4 | 5.8 | 6.9 | 13 Feb 2025 | 21 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 6.3 | 5.4 | 7.3 | 13 Jun 2025 | 24 May 2026 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 6.1 | 6.1 | 6.1 | 24 Apr 2025 | 24 Apr 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 6.0 | 6.0 | 6.0 | 6 May 2025 | 6 May 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 5.9 | 5.9 | 5.9 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 | 24 Apr 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 3.1 | 2.8 | 3.5 | 16 Mar 2025 | 20 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 2.9 | 2.9 | 2.9 | 14 Jan 2025 | 14 Jan 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 1.4 | 1.4 | 1.4 | 9 Jun 2025 | 9 Jun 2025 |
| PepLab SolutionsCASE #VI-2026-0431 | X | 1 | 0.8 | 0.8 | 0.8 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for GHRP-6 Acetate alone.